Indian Corona Vaccine: Final trial of indigenous vaccine to be completed in two months, know how much will cost

Read Time:1 Minute, 59 Second

Corona vaccine indigenous vaccine may cost around Rs 100 The final trial of most of the Coronavirus Vaccine of Corona virus will be completed in the next two months, which will be much cheaper. The Union Health Minister Harsh Vardhan said that the indigenous vaccine trial of Kovid-19 is expected to be completed in the next one to two months. The Health Minister said this during a web conference.

The Indian Council of Medical Research (ICMR) and Bharat Biotech have started the third phase trial of covaxin (COVAXIN) this month, with 26,000 people participating. It is being told that this is the most advanced Indian experimental vaccine. Harshvardhan said, ‘We are in the final stages of the process of developing our indigenous vaccine. We are in the process of completing the Phase III trial in the next one or two months. Harsh Vardhan also reiterated that the government plans to have 20 to 25 crore Indians vaccinated by July.

It is being told that the indigenous vaccine of Corona vaccine may cost around Rs 100. However, there is no official confirmation of this yet. It is believed that indigenous vaccine of Corona will be available in India by March-April.

Corona Warriors to be given first vaccine

Recently the Health Minister had said that we are working fast in the field of vaccine. India is second to none in the world in making vaccines. The vaccine will be available to people in India by early 2021 next year. He also stated that when the corona vaccine is ready, priority will be given to health workers and the elderly (people above 65 years of age). Vaccine will then be given to those aged 50–65 years.

All the countries around the world are currently passing through the havoc of Corona. Governments of all countries are taking innovative steps to overcome this deadly virus, but the only permanent solution is vaccine. For this reason, all eyes are set on the Corona vaccine. All countries are working vigorously in this direction. At present, America is seen at the forefront of this race. The US Pfizer vaccine has undergone three trials and has proved to be effective up to 95 per cent, while the American Modern vaccine has also proved to be 94.5 per cent effective, while the UK Oxford vaccine has also proved to be very effective in trials. Know which country is preparing for the vaccine